No Further Pap Testing Needed
This 66-year-old woman does not need another Pap test, regardless of her new sexual relationship, because she has met adequate prior screening criteria with two consecutive negative HPV co-tests at ages 59 and 63.
Rationale Based on Current Guidelines
Adequate Prior Screening Criteria Met
This patient fulfills the established criteria for discontinuing cervical cancer screening 1, 2:
- She has two consecutive negative HPV co-tests (cytology + HPV testing) performed at ages 59 and 63
- These tests occurred within the required 10-year window before age 65
- Her most recent test was within 5 years (at age 63)
- She has no history of abnormal results
Strong Protective Effect of Negative Co-testing
The evidence demonstrates that negative HPV co-testing provides exceptionally strong protection against future cervical cancer 1:
- Women aged ≥50 years with successive negative co-tests have a 5-year CIN3+ risk of only 0.024% after multiple negative rounds 1
- The 5-year risk of CIN3 after 2 negative co-tests in the 10-year period before age 65 was 0.041%, with no cervical cancers diagnosed during follow-up 1
- Negative co-testing provides stronger protection than cytology alone in older women 1
Updated Exit Criteria (2026)
While the most recent 2026 American Cancer Society update recommends HPV testing at both ages 60 and 65 years as the preferred exit strategy 3, this patient's screening history with negative co-tests at ages 59 and 63 provides comparable protection. The 2020 guidelines, which she followed, required 2 consecutive negative co-tests within 10 years with the most recent within 5 years—criteria she has met 1.
New Sexual Partner Does Not Change Recommendation
Why Screening Should Not Resume
A new sexual relationship does not warrant resuming screening in adequately screened women over age 65 1:
- The 2012 USPSTF guidelines explicitly state that "screening should not resume after cessation, even with a report of a new sexual partner" 1
- The protective effect of prior negative screening persists for at least 20 years, with adequately screened women having an absolute 20-year cervical cancer risk of only 8 per 10,000 1
- HPV-related cervical carcinogenesis is a multi-step process that typically takes years to decades, not a rapid progression 1
Disease Burden Context
While approximately 1 in 5 cervical cancers are diagnosed in women ≥65 years 1, the vast majority occur in underscreened or unscreened women 1. This patient's adequate screening history places her in a very low-risk category.
Common Pitfalls to Avoid
- Do not restart screening based solely on new sexual activity in adequately screened women over 65 1
- Do not confuse the need for STI screening (which may be appropriate with a new partner) with cervical cancer screening
- Ensure the patient understands that she should still seek evaluation for any abnormal vaginal bleeding or other concerning symptoms, as screening cessation does not mean ignoring symptoms